22157.jpg
Insights on the Radiotherapy Market to 2028 - by Type, Product, Application, End-user and Geography
24 août 2021 06h53 HE | Research and Markets
Dublin, Aug. 24, 2021 (GLOBE NEWSWIRE) -- The "Radiotherapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Product, Application, and End User, and Geography" report has been...
Curium Announces Sub
Curium Announces Submission of an Investigational New Drug (IND) Application for Cu-64 PSMA I&T
24 août 2021 02h15 HE | Curium
ST. LOUIS, MO, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Curium announced today that it has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for Cu-64...
22157.jpg
Global $12.17 Billion Nuclear Medicine Markets to 2028: Beta-emitters, PET, SPECT, Alpha-emitters, Brachytherapy
29 juin 2021 04h13 HE | Research and Markets
Dublin, June 29, 2021 (GLOBE NEWSWIRE) -- The "Nuclear Medicine Market Share, Size, Trends, Industry Analysis Report, By Type; By Modality; By Application; By End-Use; By Regions; Segment Forecast,...
mono.jpg
Monopar and NorthStar Announce Patent Filing on Promising Radiopharmaceutical Discovery
24 mai 2021 08h00 HE | Monopar Therapeutics Inc.
WILMETTE, Ill. and BELOIT, Wis., May 24, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) and NorthStar Medical Radioisotopes, LLC, today announced the filing of a provisional...
22157.jpg
Global Radiopharmaceuticals Market Report 2021: High Cost of Radiopharmaceuticals is Anticipated to Limit the Growth of the Market
24 mai 2021 05h08 HE | Research and Markets
Dublin, May 24, 2021 (GLOBE NEWSWIRE) -- The "Radiopharmaceuticals Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. The...
Curium Announces Fil
Curium Announces Filing of a Generic Version of DaTscanᵀᴹ (Ioflupane I 123 Injection) in the U.S.
04 mai 2021 02h30 HE | Curium
St. Louis, MO, May 04, 2021 (GLOBE NEWSWIRE) -- Curium announced today that it submitted an abbreviated new drug application for a generic version of DaTscan (Ioflupane I 123 Injection) with the...
Curium to Expand Nob
Curium to Expand Noblesville Facility’s Workforce
28 avr. 2021 02h30 HE | Curium
St. Louis, MO, April 28, 2021 (GLOBE NEWSWIRE) -- Curium, the world’s largest nuclear medicine company, has announced plans to invest in new jobs at its Noblesville location – furthering its...
22157.jpg
Global Radiopharmaceutical Market (2020 to 2025) - by Type, Application, Procedure, End-user and Geography
15 mars 2021 06h28 HE | Research and Markets
Dublin, March 15, 2021 (GLOBE NEWSWIRE) -- The "Global Radiopharmaceutical Market (2020-2025) by Type, Application, Procedure, End-User, Geography, Competitive Analysis and the Impact of Covid-19...
RadioMedix & Curium
RadioMedix & Curium Announce Permanent HCPCS Code for DetectnetTM (copper Cu 64 dotatate injection)
26 janv. 2021 02h30 HE | Curium
St. Louis, MO, Jan. 26, 2021 (GLOBE NEWSWIRE) -- RadioMedix Inc. and its commercial partner Curium announced today that the Centers for Medicare & Medicaid Services (CMS) has granted Detectnet a...
LOGO.jpg
QSAM Biosciences Receives Favorable Safety Results in Study for its Leading Radiopharmaceutical Drug Candidate
21 janv. 2021 09h00 HE | QSAM Biosciences Inc.
Palm Beach, FL, Jan. 21, 2021 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next generation nuclear medicines for the treatment of cancer and related diseases and...